The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions. / Kolind, Mille Petersen; Nørby, Peder Lisby; Flintegaard, Thomas Veje; Berchtold, Martin Werner; Johnsen, Laust Bruun.

I: Journal of Biotechnology, Bind 147, Nr. 3-4, 2010, s. 198-204.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kolind, MP, Nørby, PL, Flintegaard, TV, Berchtold, MW & Johnsen, LB 2010, 'The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions', Journal of Biotechnology, bind 147, nr. 3-4, s. 198-204. https://doi.org/10.1016/j.jbiotec.2010.04.010

APA

Kolind, M. P., Nørby, P. L., Flintegaard, T. V., Berchtold, M. W., & Johnsen, L. B. (2010). The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions. Journal of Biotechnology, 147(3-4), 198-204. https://doi.org/10.1016/j.jbiotec.2010.04.010

Vancouver

Kolind MP, Nørby PL, Flintegaard TV, Berchtold MW, Johnsen LB. The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions. Journal of Biotechnology. 2010;147(3-4):198-204. https://doi.org/10.1016/j.jbiotec.2010.04.010

Author

Kolind, Mille Petersen ; Nørby, Peder Lisby ; Flintegaard, Thomas Veje ; Berchtold, Martin Werner ; Johnsen, Laust Bruun. / The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions. I: Journal of Biotechnology. 2010 ; Bind 147, Nr. 3-4. s. 198-204.

Bibtex

@article{a5ac8ffb00914f87bb79086b1f39e84b,
title = "The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions",
abstract = "Factor VIII (FVIII) is an important protein in the blood coagulation cascade and dysfunction or deficiency of FVIII causes haemophilia A. Replacement therapy with exogenous recombinant FVIII (rFVIII) works as a substitute for the missing or non-functioning FVIII. The rFVIII protein has been engineered extensively throughout the years to increase the low production yields that initially were obtained from mammalian cell cultures.The scope of this work was to investigate the interaction of rFVIII with the cell membrane surface of the producing cells in serum free medium. We wondered whether binding of rFVIII to the cell membrane could be a factor diminishing the production yield. We studied the contribution of the rFVIII B-domain to membrane attachment by transfecting several constructs containing increasing lengths of the B-domain into cells under serum free conditions. We found that 90% of rFVIII is attached to the cell membrane of the producing cell when the rFVIII variant contains a short B-domain (21 aa). By increasing the length of the B-domain the membrane attached fraction can be reduced to 50% of the total expressed rFVIII. Further, our studies show that the N-linked glycosylations within the B-domain have no influence on either total expression level or membrane attachment properties",
author = "Kolind, {Mille Petersen} and N{\o}rby, {Peder Lisby} and Flintegaard, {Thomas Veje} and Berchtold, {Martin Werner} and Johnsen, {Laust Bruun}",
year = "2010",
doi = "10.1016/j.jbiotec.2010.04.010",
language = "English",
volume = "147",
pages = "198--204",
journal = "Journal of Biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "3-4",

}

RIS

TY - JOUR

T1 - The B-domain of factor VIII reduces cell membrane attachement to host cells in serum free conditions

AU - Kolind, Mille Petersen

AU - Nørby, Peder Lisby

AU - Flintegaard, Thomas Veje

AU - Berchtold, Martin Werner

AU - Johnsen, Laust Bruun

PY - 2010

Y1 - 2010

N2 - Factor VIII (FVIII) is an important protein in the blood coagulation cascade and dysfunction or deficiency of FVIII causes haemophilia A. Replacement therapy with exogenous recombinant FVIII (rFVIII) works as a substitute for the missing or non-functioning FVIII. The rFVIII protein has been engineered extensively throughout the years to increase the low production yields that initially were obtained from mammalian cell cultures.The scope of this work was to investigate the interaction of rFVIII with the cell membrane surface of the producing cells in serum free medium. We wondered whether binding of rFVIII to the cell membrane could be a factor diminishing the production yield. We studied the contribution of the rFVIII B-domain to membrane attachment by transfecting several constructs containing increasing lengths of the B-domain into cells under serum free conditions. We found that 90% of rFVIII is attached to the cell membrane of the producing cell when the rFVIII variant contains a short B-domain (21 aa). By increasing the length of the B-domain the membrane attached fraction can be reduced to 50% of the total expressed rFVIII. Further, our studies show that the N-linked glycosylations within the B-domain have no influence on either total expression level or membrane attachment properties

AB - Factor VIII (FVIII) is an important protein in the blood coagulation cascade and dysfunction or deficiency of FVIII causes haemophilia A. Replacement therapy with exogenous recombinant FVIII (rFVIII) works as a substitute for the missing or non-functioning FVIII. The rFVIII protein has been engineered extensively throughout the years to increase the low production yields that initially were obtained from mammalian cell cultures.The scope of this work was to investigate the interaction of rFVIII with the cell membrane surface of the producing cells in serum free medium. We wondered whether binding of rFVIII to the cell membrane could be a factor diminishing the production yield. We studied the contribution of the rFVIII B-domain to membrane attachment by transfecting several constructs containing increasing lengths of the B-domain into cells under serum free conditions. We found that 90% of rFVIII is attached to the cell membrane of the producing cell when the rFVIII variant contains a short B-domain (21 aa). By increasing the length of the B-domain the membrane attached fraction can be reduced to 50% of the total expressed rFVIII. Further, our studies show that the N-linked glycosylations within the B-domain have no influence on either total expression level or membrane attachment properties

U2 - 10.1016/j.jbiotec.2010.04.010

DO - 10.1016/j.jbiotec.2010.04.010

M3 - Journal article

C2 - 20438774

VL - 147

SP - 198

EP - 204

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

IS - 3-4

ER -

ID: 33343923